Marked alterations in circulating inflammatory cells during cardiomyopathy development in a magnesium-deficient rat

J Kurantsin-Mills1, M M Cassidy, R E Stafford

  • 1Department of Medicine, George Washington University Medical Center, Washington, DC 20037, USA.

Insights

Magnesium deficiency in rats causes cardiomyopathy, with specific immune cells like neutrophils and lymphocytes driving inflammation. These changes correlate with lesion development, suggesting microvascular barrier alterations are key.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Nutritional Science

Background:

  • Magnesium deficiency (Mg-D) in rodents induces cardiomyopathic lesions and cardiovascular dysfunction.
  • Early molecular markers include elevated substance P, CGRP, PGE2, histamine, and inflammatory cytokines.
  • The role of specific circulating inflammatory cell subpopulations in Mg-D cardiomyopathy remains unclear.

Purpose of the Study:

  • To investigate the potential role of circulating inflammatory cell subpopulations in Mg-deficiency-induced cardiomyopathy.
  • To analyze changes in leucocyte subpopulations during the development of Mg-D cardiomyopathy.
  • To correlate leucocyte subpopulation dynamics with the progression of myocardial lesions.

Main Methods:

  • Rodents were fed a magnesium-deficient diet.
  • Flow cytochemistry was used to analyze circulating leucocyte subpopulations.
  • Leucocyte levels were monitored throughout the development of cardiomyopathy (weeks 1-4).

Main Results:

  • Progressive increases in leucocyte subpopulation pools were observed in Mg-D rats.
  • Elevated neutrophils and lymphocytes contributed to both acute (weeks 1-2) and chronic (weeks 3-4) inflammatory phases.
  • Monocytes, eosinophils, basophils, and large unstained cells increased significantly in the chronic phase (weeks 3-4).

Conclusions:

  • Circulating leucocyte subpopulation changes parallel the chronological progression of Mg-D cardiomyopathy.
  • Neutrophilia precedes myocardial leucocyte infiltration, suggesting microvascular barrier modification is a prerequisite.
  • This model highlights neurogenic inflammation's role in Mg-deficiency-induced cardiomyopathy.